Sanara MedTech's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Sanara MedTech (NASDAQ:SMTI) is scheduled to release its quarterly earnings report on March 25, 2024, with analysts predicting an EPS of $-0.13. Historical data shows mixed reactions to past earnings, with the last quarter's miss leading to a 19.36% share price increase the following day. Shares are currently trading at $37.72, down 1.75% over the last year. Investors are advised to watch for the company's guidance for future growth, which could significantly impact the stock price.
March 22, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Sanara MedTech is expected to announce its quarterly earnings with an anticipated EPS of $-0.13. Historical performance shows significant price volatility post-earnings, with the last miss resulting in a 19.36% price increase. Currently trading at $37.72, down 1.75% over the year.
Given Sanara MedTech's history of price volatility post-earnings, the upcoming report could lead to significant short-term price movement. However, the direction is uncertain, as past performance includes both positive and negative reactions. The anticipation of guidance for future growth adds another layer of uncertainty, making the short-term impact neutral.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100